Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by whatyouthinkon Jul 16, 2009 8:24pm
401 Views
Post# 16144429

Warrants

Warrants
Its been a while since my last financing with warrants attached.

This week the warrant holders all received their packages.

next week they may send in their money.

Maybe the following week the transfer agent releases their shares and the shares are actually in the subscribers' trading accounts ready to go.

So when does the news come out?

Last week of July or first week of August ?

what do you think?

Another thot - how cool that this financing will be (maybe) done back-to-front

Meaning normally the financing would be at the lower price (0 .16) and the warrants at the higher price (0.35)

Yes its win-win for those guys ... if all goes according to plan. 

The plan is to reach the next milestone (ASAP) with an MOU from Pfizer to fund each successful step going forward.

Bearing in mind that SCT still needs to prove it works. Regardless of FDA or Health Canada.

The actual deliverable product has not been proven to work safely every time.

Right now it is cutting edge science that offers investors a tempting risk/reward scenario.

There can be no doubt that Pfizer and others are watching.

Watch the gap-up to somewhere between 0.35 and 0.85 with millions traded when this partnership is announced!


Bullboard Posts